• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西咪替丁在体内外与肝微粒体的相互作用。与细胞色素P - 450形成活化复合物的过程。

Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.

作者信息

Jensen J C, Gugler R

出版信息

Biochem Pharmacol. 1985 Jun 15;34(12):2141-6. doi: 10.1016/0006-2952(85)90408-3.

DOI:10.1016/0006-2952(85)90408-3
PMID:3924056
Abstract

The O-deethylation of 7-ethoxycoumarin was inhibited in a mixed type manner by cimetidine in vitro and in microsomes isolated from rats treated with cimetidine in vivo. It was found that the inhibition was even greater if cimetidine was preincubated with the microsomal suspension in the presence of an NADPH-generating system prior to the addition of substrate. In vitro the decrease in activity was accompanied by a decrease in cytochrome P-450 content. This decrease was unaffected by the addition of EDTA to the microsomal suspensions, eliminating the possibility that free radical production was responsible for the decrease in cytochrome P-450. The decrease in activity and cytochrome P-450 content following preincubation of microsomal suspensions with cimetidine could be attenuated if potassium ferricyanide was added to the suspensions. The deethylation activity and cytochrome P-450 content of liver microsomes prepared from cimetidine-treated rats was decreased compared to control animals. The activity and cytochrome P-450 content of microsomes from cimetidine-treated rats could also be restored if microsomes were washed with potassium ferricyanide prior to incubation with substrate. It is proposed that an intermediate complex of cimetidine and cytochrome P-450 could be involved in the inhibition of microsomal metabolism by cimetidine.

摘要

西咪替丁在体外以及在从体内经西咪替丁处理的大鼠分离出的微粒体中,以混合型方式抑制7-乙氧基香豆素的O-去乙基化反应。研究发现,如果在添加底物之前,先将西咪替丁与微粒体悬浮液在存在NADPH生成系统的情况下预孵育,抑制作用会更强。在体外,活性降低伴随着细胞色素P-450含量的减少。向微粒体悬浮液中添加EDTA并不会影响这种减少,排除了自由基产生导致细胞色素P-450减少的可能性。如果向悬浮液中添加铁氰化钾,微粒体悬浮液与西咪替丁预孵育后活性和细胞色素P-450含量的减少会减弱。与对照动物相比,从经西咪替丁处理的大鼠制备的肝微粒体的去乙基化活性和细胞色素P-450含量降低。如果在与底物孵育之前用铁氰化钾洗涤微粒体,经西咪替丁处理的大鼠微粒体的活性和细胞色素P-450含量也可以恢复。有人提出,西咪替丁与细胞色素P-450的中间复合物可能参与了西咪替丁对微粒体代谢的抑制作用。

相似文献

1
Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.西咪替丁在体内外与肝微粒体的相互作用。与细胞色素P - 450形成活化复合物的过程。
Biochem Pharmacol. 1985 Jun 15;34(12):2141-6. doi: 10.1016/0006-2952(85)90408-3.
2
Inhibition by SKF 525-A of 7-ethoxycoumarin O-deethylation in microsomal and the reconstituted monooxygenase systems from PCB-treated rat livers.
Jpn J Pharmacol. 1980 Dec;30(6):841-51. doi: 10.1254/jjp.30.841.
3
[Inhibition of microsomal enzyme activity of the liver by various H2 receptor antagonists].[各种H2受体拮抗剂对肝脏微粒体酶活性的抑制作用]
Z Gastroenterol. 1987 Feb;25(2):112-8.
4
Cytochrome P-450 and ethoxycoumarin-deethylation in rat gastric microsomes: induction by 3-methylcholanthrene and inhibition by cimetidine.
Biochem Biophys Res Commun. 1981 Sep 30;102(2):784-90. doi: 10.1016/s0006-291x(81)80200-8.
5
Evidence for induction of hepatic microsomal cytochrome P-450 by cimetidine: binding and kinetic studies.
Arch Biochem Biophys. 1986 Jun;247(2):372-83. doi: 10.1016/0003-9861(86)90596-5.
6
In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes.在体内给予H2受体阻滞剂西咪替丁和雷尼替丁,可降低大鼠肝微粒体中细胞色素P450IID(CYP2D)亚家族的含量及其活性。
Int J Biochem. 1994 Jun;26(6):751-8. doi: 10.1016/0020-711x(94)90104-x.
7
On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes.
Xenobiotica. 1988 Aug;18(8):983-9. doi: 10.3109/00498258809167522.
8
The interaction of cimetidine with rat liver microsomes.西咪替丁与大鼠肝微粒体的相互作用。
Biochem Pharmacol. 1983 Mar 1;32(5):831-5. doi: 10.1016/0006-2952(83)90584-1.
9
Isolation of human hepatic microsomes and their inhibition by cimetidine and ranitidine.
Eur J Clin Pharmacol. 1985;29(2):199-206. doi: 10.1007/BF00547422.
10
The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.西咪替丁对人肝微粒体和重组CYP2D6右美沙芬O-脱甲基酶活性的影响。
Drug Metab Dispos. 2004 Apr;32(4):460-7. doi: 10.1124/dmd.32.4.460.

引用本文的文献

1
The effect of velnacrine on the mixed function oxidase system.维那克林对混合功能氧化酶系统的作用。
Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):121-5. doi: 10.1007/BF03189794.
2
Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.混合功能氧化酶抑制剂增强恶性疟原虫体外及伯氏疟原虫体内的药物敏感性
Antimicrob Agents Chemother. 1993 Jun;37(6):1318-23. doi: 10.1128/AAC.37.6.1318.
3
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.
酶抑制对人肝微粒体中他克林代谢及活化的影响。
Br J Clin Pharmacol. 1994 Jul;38(1):15-22. doi: 10.1111/j.1365-2125.1994.tb04316.x.
4
Safety of acid-suppressing drugs.抑酸药物的安全性。
Dig Dis Sci. 1995 Feb;40(2 Suppl):63S-80S. doi: 10.1007/BF02214872.
5
Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles.药物代谢抑制动力学:代谢物浓度-时间曲线的应用
J Pharmacokinet Biopharm. 1987 Oct;15(5):497-510. doi: 10.1007/BF01061759.
6
Pharmacokinetic interactions of cimetidine 1987.西咪替丁的药代动力学相互作用,1987年。
Clin Pharmacokinet. 1987 May;12(5):321-66. doi: 10.2165/00003088-198712050-00002.
7
The effects of cimetidine, ranitidine and famotidine on rat hepatic microsomal cytochrome P-450 activities.西咪替丁、雷尼替丁和法莫替丁对大鼠肝微粒体细胞色素P - 450活性的影响。
Agents Actions. 1989 Apr;27(1-2):188-91. doi: 10.1007/BF02222235.
8
An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.使用两室体外测试系统研究代谢在氨苯砜诱导的高铁血红蛋白血症中的作用。
Br J Clin Pharmacol. 1990 Dec;30(6):829-38. doi: 10.1111/j.1365-2125.1990.tb05448.x.
9
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).用于治疗胃肠道疾病的药物的临床药代动力学(第二部分)。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
10
The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.西咪替丁预孵育对人肝微粒体中氨苯砜N-羟化作用的影响。
Br J Clin Pharmacol. 1991 Jul;32(1):120-3. doi: 10.1111/j.1365-2125.1991.tb05623.x.